CI Investments Inc
REGN icon

CI Investments Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

CI Investments Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.08M Buy
11,747
+154
+1% +$118K 0.04% 226
2025
Q4 		$8.95M Buy
11,593
+6,999
+152% +$4.75M 0.04% 232
2025
Q3 		$2.58M Buy
4,594
+343
+8% +$194K 0.01% 345
2025
Q2 		$2.23M Sell
4,251
-3,487
-45% -$1.95M 0.01% 352
2025
Q1 		$4.91M Buy
7,738
+2,508
+48% +$1.73M 0.02% 302
2024
Q4 		$3.73M Sell
5,230
-1,910
-27% -$1.6M 0.01% 321
2024
Q3 		$7.51M Buy
7,140
+1,142
+19% +$1.27M 0.03% 267
2024
Q2 		$6.3M Buy
5,998
+2,263
+61% +$2.19M 0.02% 257
2024
Q1 		$3.6M Buy
3,735
+1,334
+56% +$1.27M 0.01% 306
2023
Q4 		$2.11M Sell
2,401
-284
-11% -$234K 0.01% 325
2023
Q3 		$2.21M Sell
2,685
-301
-10% -$237K 0.01% 317
2023
Q2 		$2.15M Buy
2,986
+1,075
+56% +$829K 0.01% 324
2023
Q1 		$1.57M Buy
1,911
+729
+62% +$550K 0.01% 345
2022
Q4 		$853K Buy
1,182
+218
+23% +$161K ﹤0.01% 385
2022
Q3 		$664K Buy
964
+100
+12% +$62.9K ﹤0.01% 403
2022
Q2 		$511K Sell
864
-356
-29% -$231K ﹤0.01% 470
2022
Q1 		$852K Buy
1,220
+33
+3% +$20.9K ﹤0.01% 455
2021
Q4 		$750K Buy
1,187
+83
+8% +$51K ﹤0.01% 514
2021
Q3 		$668K Buy
1,104
+386
+54% +$240K ﹤0.01% 523
2021
Q2 		$401K Sell
718
-22
-3% -$11.1K ﹤0.01% 649
2021
Q1 		$350K Buy
740
+44
+6% +$21.4K ﹤0.01% 597
2020
Q4 		$336K Sell
696
-44
-6% -$23.8K ﹤0.01% 600
2020
Q3 		$414K Buy
740
+282
+62% +$171K ﹤0.01% 444
2020
Q2 		$286K Buy
+458
New +$260K ﹤0.01% 479

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

CI Investments Inc's REGN Position: Q1 2026 in Review

CI Investments Inc increased its Regeneron Pharmaceuticals (REGN) stake by 1.3% in Q1 2026, buying an estimated $118K and bringing the position to 11,747 shares worth $9.08M. The position accounts for 0.04% of the portfolio, ranked #226.

CI Investments Inc first reported a position in REGN in Q2 2020 and has held it in 24 quarters since. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • CI Investments Inc held 11,747 shares of Regeneron Pharmaceuticals worth $9.08M as of Q1 2026.
  • CI Investments Inc bought 154 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $118K.
  • Regeneron Pharmaceuticals made up 0.04% of CI Investments Inc's portfolio in Q1 2026, its #226 holding.
  • CI Investments Inc first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
  • 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on CI Investments Inc's 13F filing for Q1 2026, filed 13 May 2026.